Skip to main content
Valiant Co.,Ltd logo

Valiant Co.,Ltd — Investor Relations & Filings

Ticker · 002643 ISIN · CNE1000019T0 LEI · 300300X9EWQN2SPPY217 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,535 across all filing types
Latest filing 2015-10-20 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002643

About Valiant Co.,Ltd

https://www.valiant-cn.com

Valiant Co., Ltd. specializes in the research, development, and manufacturing of advanced functional materials and specialty chemicals. The company's core product portfolio includes liquid crystal materials, OLED materials, and other high-purity chemicals used extensively in the electronic display industry. Additionally, it produces zeolite-based environmental materials utilized in automotive exhaust purification and industrial catalysis. Valiant Co., Ltd. serves a global clientele, providing critical components for high-tech applications in consumer electronics, telecommunications, and environmental protection. The organization maintains a strong focus on technological innovation and high-standard production processes to meet the evolving demands of the global materials science market.

Recent filings

Filing Released Lang Actions
关于前次募集资金使用情况的报告
Capital/Financing Update Classification · 95% confidence The document is titled "关于前次募集资金使用情况的报告" which translates to "Report on the Use of Previous Fundraising Proceeds." It details the use of funds raised from both the initial public offering and a non-public stock issuance, including amounts raised, usage, balances, and comparisons to disclosed plans. It references regulatory requirements from the China Securities Regulatory Commission and includes detailed financial data on fundraising and usage up to June 30, 2015. The document is comprehensive, over 14,000 characters, and contains actual financial data and analysis of fundraising usage, not just an announcement or summary. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an Annual Report (10-K) or Interim Report (IR) as it focuses specifically on fundraising usage rather than overall financial performance. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive data and is not merely announcing a report. Therefore, the best classification is CAP.
2015-10-20 Chinese
未来三年（2015-2017年）股东回报规划
Notice of Dividend Amount Classification · 90% confidence The document is titled as a "Three-Year Shareholder Return Plan (2015-2017)" issued by the company. It references regulatory guidelines from the China Securities Regulatory Commission regarding cash dividends and profit distribution policies. The content details the company's planned approach to shareholder returns, including dividend distribution methods, ratios, decision-making procedures, and adjustment mechanisms. It is a forward-looking policy document outlining how the company intends to handle shareholder returns over a multi-year period. It does not contain actual financial statements or results, nor is it an announcement of a report publication. It is not a regulatory filing or certification. The document is a formal plan related to dividends and shareholder returns, which aligns best with a Notice of Dividend Amount (DIV) type, as it sets out dividend policies and expected distributions over a period. Although it is a plan rather than a single dividend announcement, the closest category is DIV because it deals with dividend amounts, payment methods, and shareholder return policies. The document length is under 5,000 characters, but it is substantive and not merely an announcement of a report publication. Therefore, the best classification is DIV with high confidence.
2015-10-20 Chinese
非公开发行股票预案
Capital/Financing Update Classification · 100% confidence The document is titled "中节能万润股份有限公司 非公开发行股票预案" which translates to "Non-public Issuance of Shares Proposal". It details a plan for a non-public issuance of shares, including the background, purpose, issuance objects, pricing, quantity, and lock-up periods. It discusses the company's fundraising through a non-public stock issuance, the intended use of proceeds, and regulatory approvals required. The document is comprehensive and contains substantive financial and corporate information related to capital raising activities. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an announcement of a report, nor a full annual or interim report, but a detailed plan and proposal for a capital raising event. Therefore, the correct classification is CAP.
2015-10-20 Chinese
关于拟用募集资金收购MP Biomedicals,LLC100%股权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a proposed acquisition of 100% equity in MP Biomedicals, LLC by 中节能万润股份有限公司. It includes information about the transaction overview, board approvals, financial audit reports of the target company, asset valuation reports, the main terms of the equity purchase agreement, funding sources, purpose and impact of the transaction, and associated risks. The document is not a full annual or interim financial report but rather a comprehensive capital/financing update related to a significant acquisition and fundraising activity. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a simple announcement of voting results or a proxy statement. The presence of detailed transaction terms, financing plans, and risk disclosures aligns best with the Capital/Financing Update category (CAP). The document length (over 11,000 characters) and content confirm it is a substantive filing, not just a report publication announcement or regulatory filing. Therefore, the classification is CAP with high confidence.
2015-10-20 Chinese
关于对子公司提供担保的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the provision of guarantees by the company for its subsidiaries related to acquisition financing. It details the guarantee amounts, parties involved, and board approvals. There is no presentation of financial statements or comprehensive financial performance data. The document is relatively short (3232 characters) and serves as a formal disclosure of a corporate action (providing guarantees) rather than a full financial report or audit. It does not fit categories like Annual Report, Interim Report, or Audit Report. It is a regulatory announcement about a corporate guarantee, which aligns best with Regulatory Filings (RNS).
2015-10-20 Chinese
拟收购MP BIOMEDICALS, LLC股权项目资产评估报告书
Audit Report / Information Classification · 95% confidence The document is titled as an "资产评估报告书" which translates to "Asset Valuation Report" related to the acquisition of MP BIOMEDICALS, LLC by 中节能万润股份有限公司. It contains detailed asset evaluation, financial data, company background, and valuation methods. The report is dated 2015 and includes comprehensive financial and operational information about the target company and its subsidiaries. This is a standalone asset valuation report prepared for a specific transaction (acquisition). It is not an annual report, earnings release, or any other regulatory filing. It is not a simple announcement or a certification letter but a full detailed valuation report. Therefore, the most appropriate classification is Audit Report / Information (AR), as it is a standalone report related to asset valuation and due diligence for acquisition purposes, which fits under audit/information reports rather than full annual reports or M&A filings. H1 2015
2015-10-20 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.